Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

Clinical trial NCT07652294 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07652294
Sponsor: Spyre Therapeutics, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Inflammatory Bowel Diseases Colitis Colitis, Ulcerative

Start date: 2026-06-08
Primary completion: 2029-03-02
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.